Noordermeer, Sylvie M.
Adam, Salomé
Setiaputra, Dheva
Barazas, Marco
Pettitt, Stephen J.
Ling, Alexanda K.
Olivieri, Michele
Álvarez-Quilón, Alejandro
Moatti, Nathalie
Zimmermann, Michal
Annunziato, Stefano
Krastev, Dragomir B.
Song, Feifei
Brandsma, Inger
Frankum, Jessica
Brough, Rachel
Sherker, Alana
Landry, Sébastien
Szilard, Rachel K.
Munro, Meagan M.
McEwan, Andrea
Goullet de Rugy, Théo
Lin, Zhen-Yuan
Hart, Traver
Moffat, Jason
Gingras, Anne-Claude
Martin, Alberto
van Attikum, Haico
Jonkers, Jos
Lord, Christopher J.
Rottenberg, Sven
Durocher, Daniel
Article History
Received: 4 January 2018
Accepted: 15 May 2018
First Online: 18 July 2018
Competing interests
: D.D. and T.H. are advisors to Repare Therapeutics. C.J.L. is a named inventor on patents describing the use of PARP inhibitors (DK3044221 (T3), ES2611504 (T3), US2014378525 (A1), WO2008020180 (A2), WO2009027650 (A1)) and stands to gain from their use as part of the ICR ‘Rewards to Inventors’ scheme.